Form 8-K - Current report:
SEC Accession No. 0001193125-16-482022
Filing Date
2016-02-26
Accepted
2016-02-26 16:16:41
Documents
1
Period of Report
2016-02-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d295987d8k.htm 8-K 14009
  Complete submission text file 0001193125-16-482022.txt   15278
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 161462050
SIC: 2835 In Vitro & In Vivo Diagnostic Substances